Pay in 4 interest-free payments of $30.00 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
and Hyperalgesic Priming in the Rat
InChi: InChI=1S/C23H36O7
The active metabolite of nabumetone is felt to be the compound primarily responsible for therapeutic effect
exhibits neuroprotective and antiapoptotic activity against several neurotoxins in cell culture
Xanomeline s a muscarinic acetylcholine receptor agonist with reasonable selectivity for the M1 and M4 subtypes
Sumanirole maleate - CAS# 179386-44-8 Catalog No.:M11393-2 and Hyperalgesic Priming in theSumanirole, also known as PNU 95666, is a highly selective D2 receptor full agonist, the first of its kind to be discovered. It was developed for the treatment of Parkinson's disease and restless leg syndrome. While it has never been approved for medical use, it is a highly valuable tool compound for basic research to identify neurobiological mechanisms that are based on a dopamine D2 linked (vs. D1, D3, D4, and D5 linked) mechanism of action. Product